We are live on ! Find out more
PAI

ProQuest Associates IV Portfolio holdings

AUM $53M
1-Year Est. Return 3.35%
This Fund
S&P 500
This Quarter Est. Return
+24.59%
1 Year Est. Return
+3.35%
3 Year Est. Return
+113.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$518M
AUM Growth
+$95.7M
Cap. Flow
-$910K
Cap. Flow %
-0.18%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ZSAN
Zosano Pharma Corporation
ZSAN
+$910K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$424M 81.8%
4,780,188
– –
AGRX
2
DELISTED
Agile Therapeutics
AGRX
$45.6M 8.79%
2,334
– –
IMDZ
3
DELISTED
Immune Design Corp.
IMDZ
$39.4M 7.61%
1,962,720
– –
ANTH
4
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$8.82M 1.7%
237,500
– –
SVRA icon
5
Savara
SVRA
$1.08B
$536K 0.1%
18,228
– –
ZSAN
6
DELISTED
Zosano Pharma Corporation
ZSAN
– –
-328
Closed -$910K

Similar funds

CCP
Centaur Capital Partners Southlake, Texas $54.1M AUM 12.4% 1-Year Est. Return
CLA
Cranberry Lake Advisors Houston, Texas $50.6M AUM 5.12% 1-Year Est. Return
HC
Hampstead Capital London, United Kingdom $55.8M AUM 2.76% 1-Year Est. Return
SF
Schooner Foundation Boston, Massachusetts $49.6M AUM 9.4% 1-Year Est. Return
DIV
DCM International V Menlo Park, California $47.8M AUM 19.52% 1-Year Est. Return
MGPI
Maveron General Partner III Seattle, Washington $46.7M AUM 35.29% 1-Year Est. Return
MCAI
Meritech Capital Associates III Palo Alto, California $45.8M AUM 24.9% 1-Year Est. Return
P
PhaseCapital New York $45.2M AUM 8.85% 1-Year Est. Return

ProQuest Associates IV's Q4 2015 Portfolio in Review

As of Q4 2015, ProQuest Associates IV held 6 positions worth $518M, up 23% from $423M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ProQuest Associates IV's Q4 2015 filing shows 1 closed position. The largest sale was Zosano Pharma Corporation, an estimated $910K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ProQuest Associates IV fully exited Zosano Pharma Corporation in Q4 2015, selling an estimated $910K.
  • ProQuest Associates IV's ten largest holdings make up 100% of its $518M portfolio in Q4 2015.
  • ProQuest Associates IV opened 0 new positions and closed 1 in Q4 2015.
  • ProQuest Associates IV's portfolio value rose 23% quarter-over-quarter to $518M.

Based on ProQuest Associates IV's 13F filing for Q4 2015, filed 12 Feb 2016.